gogreenliner.blogg.se

Harpoon therapeutics stock
Harpoon therapeutics stock













The company’s shares operating in the technology space managed to set trading volume around 2883,185 for the day, which was markedly lower than the average daily volume of the shares. The stock’s price range for the 52-week period managed to maintain the performance between $39.00 and $114.09. shares are logging -44.44% above the high price during the 52-week period and 62.54% above the low price point for the same time frame. Price records that include a history of low and high prices over a 52-week period can reveal a lot about a stock’s current state and future performance. (TTD) had a full year performance of -20.15% We have set up the Alert Service to help smart investors take full advantage of small cap stocks that are designed for big returns.Ĭlick here for full details and to join for free, For stock market investors, this means that such cheap small cap stocks are likely to see a huge jump. He buys valuable assets when they are too cheap.

harpoon therapeutics stock

The world’s biggest investor – Warren Buffett – has a simple formula for making big money in the markets. The 1-year high price for the company’s stock was recorded on 01/03/22 of $93.26, while the lowest price for the same time period was $39.00, recorded on 07/14/22.

harpoon therapeutics stock

has a very good performance when it comes to market performance. (NASDAQ:TTD) today announced financial results for the second quarter ended June 30, 2022. The Trade Desk, Inc., a provider of a global technology platform for advertising buyers.

harpoon therapeutics stock

Most recently in news on August 9, 2022, The Trade Desk reported second quarter 2022 financial results. The stock rose to $65.405 after an opening rate of $64.10 during the previous session, while the lowest price ever recorded was $63.94 before closing at $63.13. (TTD), which, to be very precise, is $63.39. Let’s start with the current stock price of Trade Desk Inc.















Harpoon therapeutics stock